T-CELL LYMPHOMA REFRACTORY

T-CELL LYMPHOMA REFRACTORY was reported 35 times

T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 4 0.0047
1 MESNA INJECTION 11 0.0013
2 MESNA 11 0.0013
3 ETOPOSIDE PHOSPHATE 2 0.0012
4 IFOSFAMIDE FOR INJECTION 25 0.0012
5 ETOPOSIDE 24 0.0003
6 DOXORUBICIN 12 0.0001
7 DOXORUBICIN HYDROCHLORIDE 4 0.0001
8 CARBOPLATIN 15 0.0001
9 FILGRASTIM 3 0.0001
10 CYCLOPHOSPHAMIDE FOR INJECTION 13 0.0001
11 CYCLOPHOSPHAMIDE 13 0.0001
12 VINCRISTINE SULFATE 2 0.0001
13 DEXAMETHASONE 1.5 MG 17 0.0001
14 DEXAMETHASONE 17 0.0001
15 PREDNISOLONE ORAL SOLUTION 9 0.0000
16 INFLIXIMAB 10 0.0000
17 CISPLATIN 3 0.0000
18 CARFILZOMIB 1 0.0000
19 VEDOLIZUMAB 3 0.0000
20 RITUXIMAB 7 0.0000
21 METHOTREXATE SODIUM 12 0.0000
22 GEMCITABINE HYDROCHLORIDE 1 0.0000
23 PREDNISONE 9 0.0000
24 CYTARABINE 1 0.0000